A randomised controlled trial of early intervention with oral favipiravir in patients hospitalised with COVID-19 (PIONEER Trial)
Christopher M. Orton(University of Hull), Michael Pelly(University of Hull), Brenda Crabtree‐Ramírez(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Marta Boffito(Chelsea and Westminster Hospital NHS Foundation Trust), Francesca Conway(University of Hull), Cielito Caneja, Breno Santos(Hospital Nossa Senhora da Conceição), Beatriz Grinsztejn(Fundação Oswaldo Cruz), James Tonkin(Chelsea and Westminster Hospital NHS Foundation Trust), Pankaj Bhavsar(University of Hull), Anda Samson(University of Hull), Craig Leaper(University of Hull), Andrew I. Ritchie(University of Hull), Anton Pozniak, Gavin C. Donaldson(Boehringer Ingelheim (Egypt)), Bavithra Vijayakumar(Manchester University NHS Foundation Trust), Anand Tana(Royal Brompton Hospital), Pallav L. Shah(Guy's and St Thomas' NHS Foundation Trust), Maria P D Riberio(University of Hull), Sandra Wagner Cardoso(Instituto Evandro Chagas), Mark R. Johnson(Chelsea and Westminster Hospital NHS Foundation Trust), Bobby Mann(University of Hull), Dexter Wiseman(University of Hull)
10.01 - Respiratory infections and bronchiectasis
September 4, 2022
Cited by 1
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV
|New England Journal of Medicine|2006|886
Effectiveness and Safety of Bronchial Thermoplasty in the Treatment of Severe Asthma: A Multicenter, Randomized, Double-Blind, Sham-Controlled Clinical Trial
|American Journal of Respiratory and Critical Care Medicine|2009|686